Latest Insider Transactions at Protagonist Therapeutics, Inc (PTGX)
This section provides a real-time view of insider transactions for Protagonist Therapeutics, Inc (PTGX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Protagonist Therapeutics, Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Protagonist Therapeutics, Inc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 19
2024
|
Dinesh V Ph D Patel President and CEO |
SELL
Bona fide gift
|
Direct |
1,000
-0.19%
|
-
|
|
Nov 15
2024
|
Arturo Md Molina Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,906
-3.94%
|
$76,240
$40.98 P/Share
|
|
Sep 11
2024
|
Asif Ali Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
14,203
-15.74%
|
$624,932
$44.53 P/Share
|
|
Sep 11
2024
|
Asif Ali Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+12.05%
|
$180,000
$15.68 P/Share
|
|
Sep 10
2024
|
William D. Waddill Director |
SELL
Open market or private sale
|
Direct |
8,000
-40.0%
|
$360,000
$45.0 P/Share
|
|
Sep 10
2024
|
William D. Waddill Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+28.57%
|
$96,000
$12.88 P/Share
|
|
Jul 24
2024
|
William D. Waddill Director |
SELL
Open market or private sale
|
Direct |
8,000
-40.0%
|
$320,000
$40.0 P/Share
|
|
Jul 24
2024
|
William D. Waddill Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+28.57%
|
$96,000
$12.88 P/Share
|
|
Jun 13
2024
|
Dinesh V Ph D Patel President and CEO |
SELL
Bona fide gift
|
Direct |
1,000
-0.19%
|
-
|
|
Jun 07
2024
|
Dinesh V Ph D Patel President and CEO |
SELL
Open market or private sale
|
Direct |
35,000
-6.36%
|
$1,225,000
$35.19 P/Share
|
|
Jun 07
2024
|
William D. Waddill Director |
SELL
Open market or private sale
|
Direct |
8,000
-40.0%
|
$280,000
$35.0 P/Share
|
|
Jun 07
2024
|
William D. Waddill Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+28.57%
|
$96,000
$12.88 P/Share
|
|
Apr 18
2024
|
Asif Ali Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,234
-3.21%
|
$30,850
$25.11 P/Share
|
|
Apr 01
2024
|
Dinesh V Ph D Patel President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-4.35%
|
$700,000
$28.31 P/Share
|
|
Mar 07
2024
|
Harold E Selick Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,490
+18.82%
|
$6,490
$1.89 P/Share
|
|
Mar 01
2024
|
Asif Ali Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
14,248
-14.16%
|
$455,936
$32.28 P/Share
|
|
Mar 01
2024
|
Asif Ali Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+18.56%
|
$144,000
$12.17 P/Share
|
|
Mar 01
2024
|
William D. Waddill Director |
SELL
Open market or private sale
|
Direct |
12,975
-51.95%
|
$402,225
$31.34 P/Share
|
|
Mar 01
2024
|
William D. Waddill Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,975
+34.19%
|
$77,850
$6.09 P/Share
|
|
Mar 01
2024
|
Dinesh V Ph D Patel President and CEO |
SELL
Open market or private sale
|
Direct |
30,000
-4.96%
|
$930,000
$31.62 P/Share
|
|
Feb 29
2024
|
Asif Ali Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
9,939
-10.2%
|
$298,170
$30.81 P/Share
|
|
Feb 26
2024
|
Suneel Gupta Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,282
-2.28%
|
$124,178
$29.53 P/Share
|
|
Feb 26
2024
|
Dinesh V Ph D Patel President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,915
-1.77%
|
$316,535
$29.53 P/Share
|
|
Feb 15
2024
|
Dinesh V Ph D Patel President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,717
-0.6%
|
$104,076
$28.23 P/Share
|
|
Jan 16
2024
|
Asif Ali Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,452
-2.79%
|
$34,848
$24.63 P/Share
|
|
Jan 16
2024
|
Arturo Md Molina Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
427
-0.88%
|
$10,248
$24.63 P/Share
|
|
Jan 09
2024
|
Suneel Gupta Chief Development Officer |
SELL
Open market or private sale
|
Direct |
5,000
-2.6%
|
$125,000
$25.0 P/Share
|
|
Jan 09
2024
|
Suneel Gupta Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.53%
|
$35,000
$7.38 P/Share
|
|
Jan 02
2024
|
Suneel Gupta Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,250
+9.31%
|
-
|
|
Jan 02
2024
|
Dinesh V Ph D Patel President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
84,875
+12.05%
|
-
|
|
Jan 02
2024
|
Asif Ali Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,000
+28.75%
|
-
|
|
Jan 02
2024
|
Arturo Md Molina Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,250
+34.99%
|
-
|
|
Dec 13
2023
|
Dinesh V Ph D Patel President and CEO |
SELL
Open market or private sale
|
Direct |
75,000
-12.31%
|
$1,500,000
$20.08 P/Share
|
|
Nov 15
2023
|
Arturo Md Molina Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,848
-7.58%
|
$29,568
$16.24 P/Share
|
|
Oct 19
2023
|
Suneel Gupta Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+10.62%
|
$140,000
$7.38 P/Share
|
|
Oct 18
2023
|
Dinesh V Ph D Patel President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+0.98%
|
$24,000
$4.21 P/Share
|
|
May 31
2023
|
Dinesh V Ph D Patel President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,165
-1.98%
|
$316,290
$26.07 P/Share
|
|
May 31
2023
|
Dinesh V Ph D Patel President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+4.65%
|
-
|
|
May 31
2023
|
Suneel Gupta Chief Development Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,150
-2.73%
|
$107,900
$26.07 P/Share
|
|
May 31
2023
|
Suneel Gupta Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+7.31%
|
-
|
|
May 31
2023
|
Asif Ali Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,150
-11.79%
|
$107,900
$26.07 P/Share
|
|
May 31
2023
|
Asif Ali Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+25.43%
|
-
|
|
Apr 18
2023
|
Asif Ali Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,189
-4.88%
|
$27,347
$23.21 P/Share
|
|
Apr 10
2023
|
Harold E Selick Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,196
+22.37%
|
$0
$0.87 P/Share
|
|
Feb 22
2023
|
Dinesh V Ph D Patel President and CEO |
SELL
Bona fide gift
|
Direct |
10,000
-1.69%
|
-
|
|
Jan 16
2023
|
Suneel Gupta Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,625
+12.99%
|
-
|
|
Jan 16
2023
|
Arturo Md Molina Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,125
+11.36%
|
-
|
|
Jan 16
2023
|
Asif Ali Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,625
+30.36%
|
-
|
|
Dec 28
2022
|
Dinesh V Ph D Patel President and CEO |
SELL
Bona fide gift
|
Direct |
3,116
-0.52%
|
-
|
|
Nov 16
2022
|
David Y Liu Chief R&D Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
100,479
+13.75%
|
$200,958
$2.0 P/Share
|